[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]  BioTech Visionary [@BioTechVisions](/creator/twitter/BioTechVisions) on x XX followers Created: 2025-07-25 15:07:49 UTC 🌟 BMS Taps AstraZeneca Veteran Cristian Massacesi as New CMO & Head of Development Big leadership shake-up at BMS! Dr. Cristian Massacesi joins Bristol Myers Squibb as Executive VP, Chief Medical Officer & Head of Development, starting August 1, 2025. He will oversee all early and late-stage product development and sit on the exec leadership team. Massacesi brings a rich track record—from AstraZeneca and Alexion—where he led global oncology R&D and oversaw over XXX clinical trials, culminating in key regulatory approvals. He's widely respected for championing innovation in bispecific antibody design and integrating multi-modal strategies like ADCs for more effective cancer therapy. With a proven ability to build high-performing global teams and transform oncology pipelines, Massacesi's appointment arrives during a pivotal era of expansion and diversification for BMS. A bold move that underscores their commitment to breakthrough medicine and cross-therapeutic excellence. #BMS #Leadership #CristianMassacesi #CMO #ClinicalDevelopment #Oncology #Biotech #DrugDiscovery  XX engagements  **Related Topics** [vp](/topic/vp) [bms](/topic/bms) [$azn](/topic/$azn) [stocks healthcare](/topic/stocks-healthcare) [$bmy](/topic/$bmy) [Post Link](https://x.com/BioTechVisions/status/1948762117462786297)
[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]
BioTech Visionary @BioTechVisions on x XX followers
Created: 2025-07-25 15:07:49 UTC
🌟 BMS Taps AstraZeneca Veteran Cristian Massacesi as New CMO & Head of Development
Big leadership shake-up at BMS! Dr. Cristian Massacesi joins Bristol Myers Squibb as Executive VP, Chief Medical Officer & Head of Development, starting August 1, 2025. He will oversee all early and late-stage product development and sit on the exec leadership team.
Massacesi brings a rich track record—from AstraZeneca and Alexion—where he led global oncology R&D and oversaw over XXX clinical trials, culminating in key regulatory approvals. He's widely respected for championing innovation in bispecific antibody design and integrating multi-modal strategies like ADCs for more effective cancer therapy.
With a proven ability to build high-performing global teams and transform oncology pipelines, Massacesi's appointment arrives during a pivotal era of expansion and diversification for BMS. A bold move that underscores their commitment to breakthrough medicine and cross-therapeutic excellence.
#BMS #Leadership #CristianMassacesi #CMO #ClinicalDevelopment #Oncology #Biotech #DrugDiscovery
XX engagements
Related Topics vp bms $azn stocks healthcare $bmy